In patients with chronic myeloid leukemia (CML), a prospective, long-term study has found that hematopoietic stem cell transplantation (HSCT) and drug therapy yielded similar 10-year survival outcomes.
Cancer Network Staff
Advertisement
Articles by Cancer Network Staff
Advertisement
Latest Updated Articles
- HSCT in CML Offers Similar Outcomes to TKI Therapy
Published: October 24th 2015 | Updated:
